1. Vesicular monoamine transporter 2 inhibitors for tardive dyskinesia: effectiveness and value : final evidence report Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 22, 2017 Subject(s): Membrane Transport Modulators -- therapeutic useTardive Dyskinesia -- drug therapyVesicular Monoamine Transport Proteins -- antagonists & inhibitorsAntipsychotic Agents -- adverse effectsComparative Effectiveness ResearchMembrane Transport Modulators -- adverse effectsMembrane Transport Modulators -- economicsTardive Dyskinesia -- chemically inducedHumansUnited States
